Table 1.
Control | Chronic MS | OV+MS | OV | ||
---|---|---|---|---|---|
Fatigue index | 0.47 ± 0.09a | 0.36 ± 0.03b | 0.65 ± 0.11c | 0.64 ± 0.08c | |
Maximum twitch tension (N) | 0.35 ± 0.10a | 0.35 ± 0.07a | 0.52 ± 0.10b | 0.48 ± 0.08b | |
Maximum twitch tension per g EDL (N g−1) | 2.41 ± 0.64ab | 1.90 ± 0.44a | 2.72 ± 0.60b | 2.54 ± 0.40ab | |
Mean femoral flow (ml min−1 g−1) | Rest | 8.13 ± 1.62a | 5.37 ± 1.12b | 6.38 ± 2.77ab | 5.58 ± 1.47b |
End‐stimulation | 11.70 ± 2.49a | 7.81 ± 1.90b | 10.56 ± 3.46a | 10.44 ± 1.09a | |
Peak (systolic) femoral flow (ml min−1 g−1) | Rest | 27.00 ± 6.79a | 14.82 ± 2.63b | 20.52 ± 5.24b | 17.64 ± 4.17b |
End‐stimulation | 34.46 ± 8.24a | 19.26 ± 5.39b | 29.48 ± 7.83a | 28.20 ± 6.51ab | |
Flow amplitude (ml min−1 g−1) | Rest | 25.22 ± 7.00a | 13.39 ± 2.92b | 18.95 ± 4.80ab | 16.50 ± 4.25b |
End‐stimulation | 31.40 ± 8.45a | 16.46 ± 5.26b | 25.60 ± 8.05ab | 24.92 ± 7.13ab | |
FVC (ml min‐1 mmHg−1 g−1) | Rest | 0.067 ± 0.013a | 0.042 ± 0.008b | 0.053 ± 0.022ab | 0.047 ± 0.013b |
End‐stimulation | 0.100 ± 0.020a | 0.062 ± 0.016b | 0.089 ± 0.024a | 0.086 ± 0.015ab | |
Hyperaemic scope | 1.50 ± 0.24a | 1.48 ± 0.24ab | 1.79 ± 0.31ab | 1.92 ± 0.51b |
Unshared superscript letters denote statistical significance (P < 0.05) as assessed by Tukey post hoc tests.